Quantcast
Channel: Business Insider
Viewing all articles
Browse latest Browse all 117573

Steve Cohen disclosed a 2.8 million-share stake in a tiny pharmaceutical company that jumped 432% on Tuesday (CPXX)

$
0
0

steve cohen

In a filing out on Tuesday after the market closed, hedge fund manager Steve Cohen revealed an 8.3% ownership stake in tiny company Celator Pharmaceuticals.

You might recognize the name. Celator shares jumped 432% in trading on Tuesday after announcing a successful test of its new drug targeting a form of leukemia.

Through his family-office fund, Point72 Asset Management, Cohen acquired just over 2.8 million shares some time in the past 10 days.

This position stood as of Monday's close.

Tuesday's disclosure came in a 13G filing, required whenever an investor takes a stake in a company equal to more than 5% of a company. Investors have a 10-day period from the time of purchase to disclose this position.

Based on Tuesday's trading, Cohen's stake increased in value by about $20.7 million from Monday's close to Tuesday's. Tuesday's filing doesn't say what Cohen's cost basis for the stake is.

Each share of Celator has been trading between about $1.50 and $2.10 over the last few weeks.

So while this isn't a huge part of Cohen's portfolio — Point72 has around $11 billion in assets — it's not bad for a day's work.

Screen Shot 2016 03 15 at 4.49.25 PM

SEE ALSO: This pharmaceutical company got great news about its cancer-fighting drug, and the stock skyrocketed over 400%

Join the conversation about this story »

NOW WATCH: Here's what fruits and vegetables looked like before we domesticated them


Viewing all articles
Browse latest Browse all 117573

Trending Articles